Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels
Hussein N. Rubaiy, Melanie J. Ludlow, Karsten Siems, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 16, pp. 3361-3368
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research
Angelo A. Izzo, Mauro Martins Teixeira, S P H Alexander, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2169-2178
Open Access | Times Cited: 194
TRPC channels: Structure, function, regulation and recent advances in small molecular probes
Hongbo Wang, Xiaoding Cheng, Jinbin Tian, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107497-107497
Open Access | Times Cited: 173
ORAI Calcium Channels: Regulation, Function, Pharmacology, and Therapeutic Targets
Hussein N. Rubaiy
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 162-162
Open Access | Times Cited: 19
Small molecules targeting canonical transient receptor potential channels: an update
Hua Liu, Min Fu, Yifan Zhang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103951-103951
Closed Access | Times Cited: 6
Treasure troves of pharmacological tools to study transient receptor potential canonical 1/4/5 channels
Hussein N. Rubaiy
British Journal of Pharmacology (2019) Vol. 176, Iss. 7, pp. 832-846
Open Access | Times Cited: 48
Transient Receptor Potential channels (TRP) in GtoPdb v.2023.2
Nathaniel T. Blair, Ana I. Caceres, Ingrid Carvacho, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 13
Potent, selective, and subunit‐dependent activation of TRPC5 channels by a xanthine derivative
Aisling Minard, Claudia Bauer, Eulashini Chuntharpursat‐Bon, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 20, pp. 3924-3938
Open Access | Times Cited: 39
Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype
Karina Kofman, Michael Levin
Progress in Biophysics and Molecular Biology (2024) Vol. 191, pp. 25-39
Closed Access | Times Cited: 4
TRPC-mediated Ca2+ signaling and control of cellular functions
Sanja Ćurčić, Romana Schober, Rainer Schindl, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 94, pp. 28-39
Closed Access | Times Cited: 32
Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903
Alireza Baradaran‐Heravi, Claudia Bauer, Isabelle B. Pickles, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 2, pp. 101546-101546
Open Access | Times Cited: 14
The TRPC5 receptor as pharmacological target for pain and metabolic disease
Pragyanshu Khare, Jagdish Chand, Alexandra Ptakova, et al.
Pharmacology & Therapeutics (2024) Vol. 263, pp. 108727-108727
Open Access | Times Cited: 2
Canonical Transient Receptor Potential (TRPC) Channels in Nociception and Pathological Pain
Zhi‐Chuan Sun, Sui‐Bin Ma, Wen‐Guang Chu, et al.
Neural Plasticity (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 20
Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials
Yuanyuan Gao, Wen Tian, Huinan Zhang, et al.
Archives of Pharmacal Research (2021) Vol. 44, Iss. 4, pp. 354-377
Open Access | Times Cited: 16
Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms
Essa M. Bajalia, Farah B. Azzouz, Danielle A. Chism, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3278-3278
Open Access | Times Cited: 10
Xanthine-based photoaffinity probes allow assessment of ligand engagement by TRPC5 channels
Claudia Bauer, Aisling Minard, Isabelle B. Pickles, et al.
RSC Chemical Biology (2020) Vol. 1, Iss. 5, pp. 436-448
Open Access | Times Cited: 12
Expression of pH-Sensitive TRPC4 in Common Skin Tumors
Bernadett Kurz, Hannah Philine Michael, Antonia Förch, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1037-1037
Open Access | Times Cited: 4
TRPC1: The housekeeper of the hippocampus
Julia Skerjanz, Lena Bauernhofer, Kerstin Lenk, et al.
Cell Calcium (2024) Vol. 123, pp. 102933-102933
Open Access | Times Cited: 1
Antitumor and antiangiogenic effects of Tonantzitlolone B, an uncommon diterpene from Stillingia loranthacea
Renata Albuquerque de Abrantes, Tatianne Mota Batista, Vivianne Mendes Mangueira, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 395, Iss. 2, pp. 267-274
Closed Access | Times Cited: 7
Transient Receptor Potential channels (TRP) in GtoPdb v.2023.1
Nathaniel T. Blair, Ingrid Carvacho, Dipayan Chaudhuri, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Transient Receptor Potential channels (TRP) in GtoPdb v.2023.3
Nathaniel T. Blair, Ana I. Caceres, Ingrid Carvacho, et al.
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 3
Open Access | Times Cited: 2
Transient Receptor Potential Canonical (TRPC) as a Therapeutic Drug Target
Hussein N. Rubaiy
Springer eBooks (2024), pp. 357-388
Closed Access
Role of TRP channels in carcinogenesis and metastasis: Pathophysiology and regulation by non-coding RNAs
Assiya Turgambayeva, Samal Duisekova, Gulnara Tashenova, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 2, pp. 359-366
Closed Access | Times Cited: 1
Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition
Zhenhua Wu, Jean‐Simon Suppo, Sarka Tumova, et al.
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 9, pp. 1711-1716
Open Access | Times Cited: 2
Xanthine-Based Photoaffinity Probes Allow Assessment of Ligand Engagement by TRPC5 Channels
Claudia Bauer, Aisling Minard, Isabelle B. Pickles, et al.
(2020)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top